designer491/iStock via Getty Images Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA)
Martin Barraud French biotech Valneva SE (NASDAQ:VALN) announced Thursday a partnership with Australian company CSL
diegograndi The member states of the World Health Organization (WHO) on Tuesday adopted a landmark
designer491/iStock via Getty Images The U.S. health officials have recommended a pause in the use
Valneva press release (NASDAQ:VALN): Q1 Total revenues were €49.2 million compared to €32.8 million for
designer491/iStock via Getty Images Valneva (NASDAQ:VALN) ADRs fell on Wednesday after the French biotech said
designer491/iStock via Getty Images Valneva’s (NASDAQ:VALN) chikungunya virus vaccine Ixchiq is now approved in the
Earnings Call Insights: Valneva SE (VALN) Q4 2024 Management View CEO Thomas Lingelbach highlighted that
Valneva press release (NASDAQ:VALN): FY Total revenues were ???169.6 million for the year ended December
The CDC is investigating Valneva’s (NASDAQ:VALN) chikungunya vaccine IXCHIQ following the hospitalizations of five individuals